A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation

Stephen Andrew LaHaye; Sabra Lynn Gibbens; David Gerald Andrew Ball; Andrew George Day; Jonas Bjerring Olesen; Allan Cameron Skanes

doi:10.1093/eurheartj/ehs167

A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation

Stephen Andrew LaHaye, Sabra Lynn Gibbens, David Gerald Andrew Ball, Andrew George Day, Jonas Bjerring Olesen, Allan Cameron Skanes

43 Citationer (Scopus)

Abstract

The availability of new antithrombotic agents, each with a unique efficacy and bleeding profile, has introduced a considerable amount of clinical uncertainty with physicians. We have developed a clinical decision aid in order to assist clinicians in determining an optimal antithrombotic regime for the prevention of stroke in patients who are newly diagnosed with non-valvular atrial fibrillation.

Originalsprog	Engelsk
Tidsskrift	Eur.Heart J.
Vol/bind	33
Udgave nummer	17
Sider (fra-til)	2163-71
Antal sider	9
ISSN	0195-668X
DOI	https://doi.org/10.1093/eurheartj/ehs167
Status	Udgivet - 2012

Adgang til dokumentet

10.1093/eurheartj/ehs167

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{9689c2672b9641e19a65373119822fab,

title = "A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation",

abstract = "The availability of new antithrombotic agents, each with a unique efficacy and bleeding profile, has introduced a considerable amount of clinical uncertainty with physicians. We have developed a clinical decision aid in order to assist clinicians in determining an optimal antithrombotic regime for the prevention of stroke in patients who are newly diagnosed with non-valvular atrial fibrillation.",

author = "LaHaye, \{Stephen Andrew\} and Gibbens, \{Sabra Lynn\} and Ball, \{David Gerald Andrew\} and Day, \{Andrew George\} and Olesen, \{Jonas Bjerring\} and Skanes, \{Allan Cameron\}",

year = "2012",

doi = "10.1093/eurheartj/ehs167",

language = "English",

volume = "33",

pages = "2163--71",

journal = "Eur.Heart J.",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "17",

}

TY - JOUR

T1 - A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation

AU - LaHaye, Stephen Andrew

AU - Gibbens, Sabra Lynn

AU - Ball, David Gerald Andrew

AU - Day, Andrew George

AU - Olesen, Jonas Bjerring

AU - Skanes, Allan Cameron

PY - 2012

Y1 - 2012

N2 - The availability of new antithrombotic agents, each with a unique efficacy and bleeding profile, has introduced a considerable amount of clinical uncertainty with physicians. We have developed a clinical decision aid in order to assist clinicians in determining an optimal antithrombotic regime for the prevention of stroke in patients who are newly diagnosed with non-valvular atrial fibrillation.

AB - The availability of new antithrombotic agents, each with a unique efficacy and bleeding profile, has introduced a considerable amount of clinical uncertainty with physicians. We have developed a clinical decision aid in order to assist clinicians in determining an optimal antithrombotic regime for the prevention of stroke in patients who are newly diagnosed with non-valvular atrial fibrillation.

UR - https://www.scopus.com/pages/publications/84866088694

U2 - 10.1093/eurheartj/ehs167

DO - 10.1093/eurheartj/ehs167

M3 - Journal article

C2 - 22752615

SN - 0195-668X

VL - 33

SP - 2163

EP - 2171

JO - Eur.Heart J.

JF - Eur.Heart J.

IS - 17

ER -

A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater